Back to Peptide Database
DermatologyInvestigational

Vialox (Pentapeptide-3)

Overview

Vialox is a synthetic pentapeptide designed to modulate neuromuscular signaling by interfering with acetylcholine receptor activation. The exact sequence is proprietary, but the peptide is marketed as a topical agent to reduce muscle contraction intensity in areas prone to dynamic wrinkles. It is positioned alongside other neuromodulating peptides as a non-invasive alternative to botulinum toxin.

Key Research Findings

Manufacturer-provided data suggest that pentapeptide-3 can reduce muscle contraction frequency in ex vivo tissue models. Small cosmetic trials have reported subjective improvements in expression line severity after 28 days, though methodological details and independent replication are lacking. No studies in indexed dermatology or pharmacology journals have validated clinical efficacy or safety profiles.

Route of Administration

Topical

Regulatory Status

Investigational

Interested in Vialox (Pentapeptide-3)?

Find a verified provider experienced with Vialox (Pentapeptide-3) protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Vialox (Pentapeptide-3) Provider

Related Peptides

Afamelanotide (Scenesse)

FDA Approved

A synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.

Argireline (Acetyl Hexapeptide-8)

Investigational

Argireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.

Matrixyl (Palmitoyl Pentapeptide-4)

Investigational

Matrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.

Matrixyl 3000

Investigational

Matrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.